Krebs Biochemicals & Industr Profit & Loss Annual

Trade
BSE: 524518 | NSE: KREBSBIO | ISIN: INE268B01013 | Sector: Biotechnology & Drugs
98.53 +15.81 (19.11%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 50.4252.1359.7053.70
Total Revenue 50.4252.1359.7053.70
Costof Revenue Total 6.5940.4767.9045.36
Gross Profit 43.8311.66-8.198.34
Selling/ General/ Admin Expenses Total 16.4727.2825.6225.87
Depreciation/ Amortization 6.776.566.305.12
Other Operating Expenses Total 36.080.160.180.05
Total Operating Expense 65.9174.4799.9976.40
Operating Income -15.49-22.34-40.29-22.70
Interest Inc( Exp) Net- Non- Op Total -46.89-19.62-41.56-43.31
Other Net 0.45-0.39-0.08-1.33
Net Income Before Taxes -19.73-24.69-44.53-28.36
Provisionfor Income Taxes 0.000.000.000.00
Net Income After Taxes -19.73-24.69-44.53-28.36
Net Income Before Extra Items -19.73-24.69-44.53-28.36
Net Income -19.73-24.69-44.53-28.36
Income Availableto Com Excl Extra Ord -19.73-24.69-44.53-28.36
Income Availableto Com Incl Extra Ord -19.73-24.69-44.53-28.36
Diluted Net Income -19.73-24.69-44.53-28.36
Diluted Weighted Average Shares 2.152.192.161.96
Diluted EPS Excluding Extra Ord Items -9.16-11.30-20.65-14.45
Diluted Normalized EPS -9.16-11.30-20.65-14.45
Unusual Expense( Income) -0.000.000.00
Gain( Loss)on Saleof Assets ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts